Marcelo F. Di Carli, Md, Facc

This study tested whether tildrakizumab, an FDA-approved drug for moderate-to-severe psoriasis, could improve how well the heart's tiny blood vessels work. Researchers enrolled 36 adults with psoriasis who also had risk factors for heart disease. They used heart imaging scans to …